Dr. Jakub Tolar is stepping down as dean at the University of Minnesota Medical School, a departure that U donors warned last year could further destabilize the university’s academic health program.
Tolar was named on Thursday, Jan. 15, as the next president, CEO and executive dean of the Baylor College of Medicine, a Houston-based center that boasts the most National Institutes of Health-funded research of any institution in Texas.
He has led the U’s Medical School since 2017. He previously ran a pioneering research institute that developed stem cell treatment for a severe and often terminal skin disease.
“Dean Tolar was presented with a compelling opportunity to serve in an elevated role as a CEO of another prestigious medical institution,” the U said in a statement. “We congratulate him and remain focused on sustaining and strengthening the University’s world-class health and health care commitment to all of Minnesota.”
Tolar was not available for an interview.
Prominent U donors raised alarms in December as word spread that Tolar was considering jobs elsewhere. They said his departure would worsen faculty instability at the state’s largest medical school and related programs for research and patient care.
The U responded at the time that philanthropic giving remained strong and predicted the university would reach an agreement to secure long-term funding of its academic health care program.
Over the years, the U’s Board of Regents has credited Tolar with leading improvements in the university’s ranking among medical schools as measured by NIH-funded research. In 2024, the most recent year available, the U ranked 25th, while Baylor was 20th, according to the Blue Ridge Institute for Medical Research.